Gudrun Pregartner
Graz, 8010, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
Serum malondialdehyde predicts mortality in patients with acute heart failure.
Journal: Redox biology
Published: February 09, 2026
Low Serum Lysophospholipids Predict Increased In-Hospital Mortality in Patients With Acute Heart Failure.
Journal: Journal of the American Heart Association
Published: January 19, 2026
Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study.
Journal: Blood cancer journal
Published: June 17, 2025
The impact of statins on pulmonary embolism severity-a retrospective data analysis.
Journal: Research and practice in thrombosis and haemostasis
Published: February 05, 2025
Sex-Related Differences in the Associations between Adiponectin and Serum Lipoproteins in Healthy Subjects and Patients with Metabolic Syndrome.
Journal: Biomedicines
Published: July 26, 2024
The misunderstanding of the R Classification-a survey amongst medical specialties treating breast cancer.
Journal: Virchows Archiv : an international journal of pathology
Published: April 07, 2024
Serum Levels of Adiponectin Are Strongly Associated with Lipoprotein Subclasses in Healthy Volunteers but Not in Patients with Metabolic Syndrome.
Journal: International journal of molecular sciences
Published: March 22, 2024
Advanced Oxidation Protein Products Are Strongly Associated with the Serum Levels and Lipid Contents of Lipoprotein Subclasses in Healthy Volunteers and Patients with Metabolic Syndrome.
Journal: Antioxidants (Basel, Switzerland)
Published: February 14, 2024
Platelet inhibitor withdrawal and outcomes after coronary artery surgery: an individual patient data meta-analysis.
Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Published: January 19, 2024
Genetic deletion of MMP12 ameliorates cardiometabolic disease by improving insulin sensitivity, systemic inflammation, and atherosclerotic features in mice.
Journal: Cardiovascular diabetology
Published: September 06, 2023
Last Updated: 09/26/2026